Department of Oncology, Xiangya Hospital, Central South University, Changsha, Hunan Province, China.
Department of Radiation Physics, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Biomed Res Int. 2020 Jul 21;2020:9097352. doi: 10.1155/2020/9097352. eCollection 2020.
To compare five techniques for the postmastectomy radiotherapy (PMRT) with simultaneous integrated boost (SIB).
Twenty patients with left-sided breast cancer were retrospectively selected. Five treatment plans were created for each patient: TomoDirect (TD), unblocked helical TomoTherapy (unb-HT), blocked HT (b-HT), hybrid intensity-modulated radiotherapy (hy-IMRT), and fixed-field IMRT (ff-IMRT). A dose of 50.4 Gy in 28 fractions to PTV and 60.2 Gy in 28 fractions to PTV were prescribed. The dosimetric parameters for targets and organs at risk (OARs), the normal tissue complication probability (NTCP), the second cancer complication probability (SCCP) for OARs, and the treatment efficiency were assessed and compared.
TD plans and hy-IMRT plans had similar good dose coverage and homogeneity for both PTV and PTV and superior dose sparing for the lungs and heart. The ff-IMRT plans had similar dosimetric results for the target volumes compared with the TD and hy-IMRT plans, but gave a relatively higher NTCP and SCCP for the lungs. The unb-HT plans exhibited the highest OAR mean dose, highest NTCP for the lungs (0.97 ± 1.25‰) and heart (4.58 ± 3.62%), and highest SCCP for the lungs (3.57 ± 0.05%) and contralateral breast (2.75 ± 0.29%) among all techniques. The b-HT plans significantly outperformed unb-HT plans with respect to the sparing of the lungs and heart. This technique also showed the best conformity index (0.73 ± 0.08) for PTV and the optimal NTCP for the lungs (0.03 ± 0.03‰) and heart (0.61 ± 0.73%). Concerning the delivery efficiency, the hy-IMRT and ff-IMRT achieved much higher delivery efficiency compared with TomoTherapy plans.
Of the five techniques studied, TD and hy-IMRT are considered the preferable options for PMRT with SIB for left-sided breast cancer treatment and can be routinely applied in clinical practice.
比较 5 种技术用于同步整合推量(SIB)后的乳腺癌根治术后放疗(PMRT)。
回顾性选择 20 例左侧乳腺癌患者。为每位患者创建了 5 种治疗计划:TomoDirect(TD)、无阻挡螺旋 TomoTherapy(unb-HT)、阻挡 TomoTherapy(b-HT)、混合强度调制放疗(hy-IMRT)和固定野强度调制放疗(ff-IMRT)。PTV 处方剂量为 50.4Gy/28 次,PTV 处方剂量为 60.2Gy/28 次。评估并比较了靶区和危及器官(OAR)的剂量学参数、正常组织并发症概率(NTCP)、OAR 的第二癌症并发症概率(SCCP)和治疗效率。
TD 计划和 hy-IMRT 计划在 PTV 和 PTV 上具有相似的良好剂量覆盖和均匀性,并且对肺和心脏具有更好的剂量保护。与 TD 和 hy-IMRT 计划相比,ff-IMRT 计划对靶区具有相似的剂量学结果,但肺的 NTCP 和 SCCP 相对较高。unb-HT 计划显示出最高的 OAR 平均剂量、肺的最高 NTCP(0.97±1.25‰)和心脏(4.58±3.62%),以及肺的最高 SCCP(3.57±0.05%)和对侧乳房(2.75±0.29%)。b-HT 计划在保护肺和心脏方面明显优于 unb-HT 计划。该技术还显示出最佳的适形性指数(0.73±0.08),用于 PTV,并且对肺(0.03±0.03‰)和心脏(0.61±0.73%)的 NTCP 最佳。关于输送效率,hy-IMRT 和 ff-IMRT 与 TomoTherapy 计划相比,实现了更高的输送效率。
在研究的 5 种技术中,TD 和 hy-IMRT 被认为是左侧乳腺癌 SIB 后 PMRT 的首选方案,可常规应用于临床实践。